Patents Assigned to CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (undivided 20% interest)
  • Publication number: 20170121367
    Abstract: The invention relates to compounds of Formula I: and pharmaceutically acceptable salts and prodrugs thereof, wherein R1, R2, and R3 are defined as set forth in the specification. The compounds are agonists of neurotrophin (such as nerve growth factor) receptors.
    Type: Application
    Filed: September 9, 2016
    Publication date: May 4, 2017
    Applicants: BIONURE FARMA, S.L. (undivided 50% interest), INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER (IDIBAPS) (undivided 30% interest), CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (undivided 20% interest)
    Inventors: Pablo VILLOSLADA, Angel MESSEGUER